| mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
0.0051 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
| mRNA |
Pazopanib |
FIMM |
pan-cancer |
AAC |
0.022 |
0.9 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.0036 |
0.9 |